Emerging evidence suggests gut microbial metabolites (SCFAs, TMAO, tryptophan metabolites) may influence amyloid-beta aggregation and neuroinflammation years before clinical symptoms, but causal mechanisms are poorly defined. Linked to 1 hypotheses and 1 targets.
Emerging evidence suggests gut microbial metabolites (SCFAs, TMAO, tryptophan metabolites) may influence amyloid-beta aggregation and neuroinflammation years before clinical symptoms, but causal mechanisms are poorly defined.
| Base Value | 45,500.00 |
| Hyp Costs Count | 1 |
| Median Cost | 650,000.00 |
| Therapeutic Potential | 0.700 |
| Importance Score | 0.500 |
| Importance Mult | 1.000 |
| Whitespace Score | 0.500 |
| Landscape Mult | 1.000 |
| Urgency Score | 0.400 |
| Urgency Mult | 0.960 |
| Confidence | 0.650 |
| Time | Method | Bounty | Reasoning |
|---|---|---|---|
| 2026-04-03 20:25 | initial_formula | $43,700 | Base $45,500 × imp 1.00 × land 1.00 × urg 0.96 |